"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 27 | 27 |
| 1998 | 0 | 33 | 33 |
| 1999 | 0 | 29 | 29 |
| 2000 | 0 | 46 | 46 |
| 2001 | 0 | 36 | 36 |
| 2002 | 0 | 38 | 38 |
| 2003 | 0 | 55 | 55 |
| 2004 | 0 | 53 | 53 |
| 2005 | 0 | 60 | 60 |
| 2006 | 0 | 73 | 73 |
| 2007 | 0 | 88 | 88 |
| 2008 | 0 | 84 | 84 |
| 2009 | 0 | 104 | 104 |
| 2010 | 0 | 107 | 107 |
| 2011 | 0 | 125 | 125 |
| 2012 | 0 | 107 | 107 |
| 2013 | 2 | 141 | 143 |
| 2014 | 1 | 175 | 176 |
| 2015 | 0 | 178 | 178 |
| 2016 | 5 | 160 | 165 |
| 2017 | 3 | 198 | 201 |
| 2018 | 1 | 232 | 233 |
| 2019 | 1 | 238 | 239 |
| 2020 | 0 | 227 | 227 |
| 2021 | 1 | 147 | 148 |
| 2022 | 0 | 72 | 72 |
| 2023 | 0 | 95 | 95 |
| 2024 | 0 | 142 | 142 |
| 2025 | 0 | 125 | 125 |
| 2026 | 0 | 30 | 30 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
Imbalance Between CD44 and STAT3 Enhances Spheroid Viability and Impairs Pembrolizumab Response in Urothelial Cancer. Anticancer Res. 2026 May; 46(5):2445-2453.
-
POD24 is a novel determinant of prognosis in patients with Waldenstr?m macroglobulinemia. Blood Adv. 2026 Apr 14; 10(7):2322-2327.
-
Intracranial mesenchymal tumor, FET::CREB fusion-positive: An integrative analysis of 81 cases. Neuro Oncol. 2026 Apr 01; 28(4):939-951.
-
Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort. J Natl Cancer Inst. 2026 Apr 01; 118(4):746-750.
-
Intermediate Risk Rhabdomyosarcoma in Very Young Children (Less Than or Equal to 24 Months) Treated on the Prior Children's Oncology Group Protocol ARST1431. Pediatr Blood Cancer. 2026 Jun; 73(6):e70293.
-
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes. Leukemia. 2026 May; 40(5):946-954.
-
Consolidative Radiotherapy for Extensive-Stage Small Cell Lung Cancer: Outcomes Based on Completeness of Consolidation and Oligometastatic State. Clin Lung Cancer. 2026 May; 27(4):14-23.
-
Cognitive Functioning in Vorinostat-Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant. Pediatr Blood Cancer. 2026 Jun; 73(6):e70259.
-
Veteran oropharyngeal cancer outcomes in the modern era: a multi-institutional retrospective analysis. Oral Oncol. 2026 May; 176:107942.
-
Treatment Decision-Making Roles and Preferences Among Adolescents and Young Adults With Cancer. Pediatr Blood Cancer. 2026 Jun; 73(6):e70235.